Global Acquired Orphan Blood Diseases Therapeutics Market 2017: Industry, Sales, Demand, Analysis, Opportunities and Forecast to 2022

 Published: Jul-2018 |  Format: PDF | YQ Research |  Number of pages: 90

<pre>This report studies the global Acquired Orphan Blood Diseases Therapeutics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Acquired Orphan Blood Diseases Therapeutics market by companies, region, type and end-use industry. Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body’s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack of red blood cells in blood, which in turn results in a decrease in platelet numbers. This decrease in platelet number causes anemia and thrombosis. Soliris (eculizumab) is a perfect example of a successful orphan blood disease drug. PNH is a potentially life-threatening blood disease, characterised by severe anemia caused by the destruction of red blood cells in the bloodstream. Bone marrow transplants can provide a cure, but the high risk procedure is suitable for only a few patients. Treatment methods include blood transfusions, iron therapy, and growth factors, but monoclonal antibody  In 2017, the global Acquired Orphan Blood Diseases Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global top players, covered Alexion Pharmaceuticals Amgen Celgene Corporation Eli Lilly Sanofi GlaxoSmithKline Cyclacel Pharmaceuticals Onconova Therapeutics Incyte Corporation CTI BioPharma Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Market segment by Type, the product can be split into Medication Bone Marrow Transplant Blood Transfusion Iron Therapy Market segment by Application, split into Hospitals Clinics Others The study objectives of this report are: To study and forecast the market size of Acquired Orphan Blood Diseases Therapeutics in global market. To analyze the global key players, SWOT analysis, value and global market share for top players. To define, describe and forecast the market by type, end use and region. To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World. To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Acquired Orphan Blood Diseases Therapeutics are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Acquired Orphan Blood Diseases Therapeutics Manufacturers Acquired Orphan Blood Diseases Therapeutics Distributors/Traders/Wholesalers Acquired Orphan Blood Diseases Therapeutics Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the Acquired Orphan Blood Diseases Therapeutics market, by end-use. Detailed analysis and profiles of additional market players.</pre>
<pre>Table of Contents Global Acquired Orphan Blood Diseases Therapeutics Market Size, Status and Forecast 2025 1 Industry Overview of Acquired Orphan Blood Diseases Therapeutics 1.1 Acquired Orphan Blood Diseases Therapeutics Market Overview 1.1.1 Acquired Orphan Blood Diseases Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Acquired Orphan Blood Diseases Therapeutics Market Size and Analysis by Regions (2013-2018) 1.2.1 United States 1.2.2 Europe 1.2.3 China 1.2.4 Japan 1.2.5 Southeast Asia 1.2.6 India 1.3 Acquired Orphan Blood Diseases Therapeutics Market by Type 1.3.1 Medication 1.3.2 Bone Marrow Transplant 1.3.3 Blood Transfusion 1.3.4 Iron Therapy 1.4 Acquired Orphan Blood Diseases Therapeutics Market by End Users/Application 1.4.1 Hospitals 1.4.2 Clinics 1.4.3 Others 2 Global Acquired Orphan Blood Diseases Therapeutics Competition Analysis by Players 2.1 Acquired Orphan Blood Diseases Therapeutics Market Size (Value) by Players (2013-2018) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 Alexion Pharmaceuticals 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) (2013-2018) 3.2 Amgen 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) (2013-2018) 3.3 Celgene Corporation 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) (2013-2018) 3.4 Eli Lilly 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) (2013-2018) 3.5 Sanofi 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) (2013-2018) 3.6 GlaxoSmithKline 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) (2013-2018) 3.7 Cyclacel Pharmaceuticals 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) (2013-2018) 3.8 Onconova Therapeutics 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) (2013-2018) 3.9 Incyte Corporation 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) (2013-2018) 3.10 CTI BioPharma 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) (2013-2018) 4 Global Acquired Orphan Blood Diseases Therapeutics Market Size by Type and Application (2013-2018) 4.1 Global Acquired Orphan Blood Diseases Therapeutics Market Size by Type (2013-2018) 4.2 Global Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) 4.3 Potential Application of Acquired Orphan Blood Diseases Therapeutics in Future 4.4 Top Consumer/End Users of Acquired Orphan Blood Diseases Therapeutics 5 United States Acquired Orphan Blood Diseases Therapeutics Development Status and Outlook 5.1 United States Acquired Orphan Blood Diseases Therapeutics Market Size (2013-2018) 5.2 United States Acquired Orphan Blood Diseases Therapeutics Market Size and Market Share by Players (2013-2018) 5.3 United States Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) 6 Europe Acquired Orphan Blood Diseases Therapeutics Development Status and Outlook 6.1 Europe Acquired Orphan Blood Diseases Therapeutics Market Size (2013-2018) 6.2 Europe Acquired Orphan Blood Diseases Therapeutics Market Size and Market Share by Players (2013-2018) 6.3 Europe Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) 7 China Acquired Orphan Blood Diseases Therapeutics Development Status and Outlook 7.1 China Acquired Orphan Blood Diseases Therapeutics Market Size (2013-2018) 7.2 China Acquired Orphan Blood Diseases Therapeutics Market Size and Market Share by Players (2013-2018) 7.3 China Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) 8 Japan Acquired Orphan Blood Diseases Therapeutics Development Status and Outlook 8.1 Japan Acquired Orphan Blood Diseases Therapeutics Market Size (2013-2018) 8.2 Japan Acquired Orphan Blood Diseases Therapeutics Market Size and Market Share by Players (2013-2018) 8.3 Japan Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) 9 Southeast Asia Acquired Orphan Blood Diseases Therapeutics Development Status and Outlook 9.1 Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size (2013-2018) 9.2 Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size and Market Share by Players (2013-2018) 9.3 Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) 10 India Acquired Orphan Blood Diseases Therapeutics Development Status and Outlook 10.1 India Acquired Orphan Blood Diseases Therapeutics Market Size (2013-2018) 10.2 India Acquired Orphan Blood Diseases Therapeutics Market Size and Market Share by Players (2013-2018) 10.3 India Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) 11 Market Forecast by Regions, Type and Application (2018-2025) 11.1 Global Acquired Orphan Blood Diseases Therapeutics Market Size (Value) by Regions (2018-2025) 11.1.1 United States Acquired Orphan Blood Diseases Therapeutics Revenue and Growth Rate (2018-2025) 11.1.2 Europe Acquired Orphan Blood Diseases Therapeutics Revenue and Growth Rate (2018-2025) 11.1.3 China Acquired Orphan Blood Diseases Therapeutics Revenue and Growth Rate (2018-2025) 11.1.4 Japan Acquired Orphan Blood Diseases Therapeutics Revenue and Growth Rate (2018-2025) 11.1.5 Southeast Asia Acquired Orphan Blood Diseases Therapeutics Revenue and Growth Rate (2018-2025) 11.1.6 India Acquired Orphan Blood Diseases Therapeutics Revenue and Growth Rate (2018-2025) 11.2 Global Acquired Orphan Blood Diseases Therapeutics Market Size (Value) by Type (2018-2025) 11.3 Global Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2018-2025) 12 Acquired Orphan Blood Diseases Therapeutics Market Dynamics 12.1 Acquired Orphan Blood Diseases Therapeutics Market Opportunities 12.2 Acquired Orphan Blood Diseases Therapeutics Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Acquired Orphan Blood Diseases Therapeutics Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Acquired Orphan Blood Diseases Therapeutics Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source List of Tables and Figures Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) Status and Outlook (2013-2018) Table Global Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) Comparison by Regions (2013-2018) Figure Global Acquired Orphan Blood Diseases Therapeutics Market Share by Regions (2013-2018) Figure United States Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure Europe Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure China Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure Japan Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure India Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018) Table Global Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018) Figure Global Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Type in 2017 Figure Medication Market Size (Million USD) and Growth Rate (2013-2018) Figure Bone Marrow Transplant Market Size (Million USD) and Growth Rate (2013-2018) Figure Blood Transfusion Market Size (Million USD) and Growth Rate (2013-2018) Figure Iron Therapy Market Size (Million USD) and Growth Rate (2013-2018) Figure Global Acquired Orphan Blood Diseases Therapeutics Market Share by Application in 2017 Figure Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate in Hospitals (2013-2018) Figure Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate in Clinics (2013-2018) Figure Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate in Others (2013-2018) Table Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Players (2013-2018) Figure Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2013 Figure Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2017 Table Alexion Pharmaceuticals Basic Information List Table Acquired Orphan Blood Diseases Therapeutics Business Revenue (Million USD) of Alexion Pharmaceuticals (2013-2018) Figure Alexion Pharmaceuticals Acquired Orphan Blood Diseases Therapeutics Business Revenue Market Share (2013-2018) Table Amgen Basic Information List Table Acquired Orphan Blood Diseases Therapeutics Business Revenue (Million USD) of Amgen (2013-2018) Figure Amgen Acquired Orphan Blood Diseases Therapeutics Business Revenue Market Share (2013-2018) Table Celgene Corporation Basic Information List Table Acquired Orphan Blood Diseases Therapeutics Business Revenue (Million USD) of Celgene Corporation (2013-2018) Figure Celgene Corporation Acquired Orphan Blood Diseases Therapeutics Business Revenue Market Share (2013-2018) Table Eli Lilly Basic Information List Table Acquired Orphan Blood Diseases Therapeutics Business Revenue (Million USD) of Eli Lilly (2013-2018) Figure Eli Lilly Acquired Orphan Blood Diseases Therapeutics Business Revenue Market Share (2013-2018) Table Sanofi Basic Information List Table Acquired Orphan Blood Diseases Therapeutics Business Revenue (Million USD) of Sanofi (2013-2018) Figure Sanofi Acquired Orphan Blood Diseases Therapeutics Business Revenue Market Share (2013-2018) Table GlaxoSmithKline Basic Information List Table Acquired Orphan Blood Diseases Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2013-2018) Figure GlaxoSmithKline Acquired Orphan Blood Diseases Therapeutics Business Revenue Market Share (2013-2018) Table Cyclacel Pharmaceuticals Basic Information List Table Acquired Orphan Blood Diseases Therapeutics Business Revenue (Million USD) of Cyclacel Pharmaceuticals (2013-2018) Figure Cyclacel Pharmaceuticals Acquired Orphan Blood Diseases Therapeutics Business Revenue Market Share (2013-2018) Table Onconova Therapeutics Basic Information List Table Acquired Orphan Blood Diseases Therapeutics Business Revenue (Million USD) of Onconova Therapeutics (2013-2018) Figure Onconova Therapeutics Acquired Orphan Blood Diseases Therapeutics Business Revenue Market Share (2013-2018) Table Incyte Corporation Basic Information List Table Acquired Orphan Blood Diseases Therapeutics Business Revenue (Million USD) of Incyte Corporation (2013-2018) Figure Incyte Corporation Acquired Orphan Blood Diseases Therapeutics Business Revenue Market Share (2013-2018) Table CTI BioPharma Basic Information List Table Acquired Orphan Blood Diseases Therapeutics Business Revenue (Million USD) of CTI BioPharma (2013-2018) Figure CTI BioPharma Acquired Orphan Blood Diseases Therapeutics Business Revenue Market Share (2013-2018) Table Global Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Product (2013-2018) Figure Global Acquired Orphan Blood Diseases Therapeutics Revenue Market Share (%) by Product (2013-2018) Figure Global Acquired Orphan Blood Diseases Therapeutics Market Share by Product in 2017 Table Global Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) Figure Global Acquired Orphan Blood Diseases Therapeutics Revenue Market Share (%) by Application in 2017 Table Top Consumer/End Users of Acquired Orphan Blood Diseases Therapeutics Figure United States Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table United States Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Players (2013-2018) Figure United States Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2013 Figure United States Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2017 Table United States Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) Figure United States Acquired Orphan Blood Diseases Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure United States Acquired Orphan Blood Diseases Therapeutics Market Size Share by Application in 2017 Figure Europe Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table Europe Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Players (2013-2018) Figure Europe Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2013 Figure Europe Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2017 Table Europe Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) Figure Europe Acquired Orphan Blood Diseases Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure Europe Acquired Orphan Blood Diseases Therapeutics Market Size Share by Application in 2017 Figure China Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table China Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Players (2013-2018) Figure China Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2013 Figure China Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2017 Table China Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) Figure China Acquired Orphan Blood Diseases Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure China Acquired Orphan Blood Diseases Therapeutics Market Size Share by Application in 2017 Figure Japan Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table Japan Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Players (2013-2018) Figure Japan Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2013 Figure Japan Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2017 Table Japan Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) Figure Japan Acquired Orphan Blood Diseases Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure Japan Acquired Orphan Blood Diseases Therapeutics Market Size Share by Application in 2017 Figure Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Players (2013-2018) Figure Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2013 Figure Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2017 Table Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) Figure Southeast Asia Acquired Orphan Blood Diseases Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size Share by Application in 2017 Figure India Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) and Growth Rate (2013-2018) Table India Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Players (2013-2018) Figure India Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2013 Figure India Acquired Orphan Blood Diseases Therapeutics Market Size Share by Players in 2017 Table India Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2013-2018) Figure India Acquired Orphan Blood Diseases Therapeutics Revenue Market Share (%) by Application (2013-2018) Figure India Acquired Orphan Blood Diseases Therapeutics Market Size Share by Application in 2017 Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size and Growth Rate (2018-2025) Table Global Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Regions (2018-2025) Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size Share (2018-2025) Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size Share by Regions in 2025 Figure United States Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Figure Europe Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Figure China Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Figure Japan Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Figure Southeast Asia Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Figure India Acquired Orphan Blood Diseases Therapeutics Revenue (Million USD) and Growth Rate (2018-2025) Table Global Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Type (2018-2025) Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size Share by Type in 2018 Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size Share by Type in 2025 Table Global Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Application (2018-2025) Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size (Million USD) by Application in 2018</pre>
Please submit the below form, to get more about this report:
Indicates required fields

Please fill your details below, to receive sample report:
Indicates required fields



Latest News

Dec-2018 |Electrical & Electronic

Six Flags Has Challenged The Toughest Biometric Privacy Law Of The US

It was 2008 when Illinois released a law that after a decade stays as the toughest biometric privacy standard in the country.  The BIPA (Biometric Information Privacy Act) impose tough rules on how the firms are able to gather sensitive infor ...

Dec-2018 |Other

Ohio Became The First State To Accept Taxes From Businesses In Bitcoin

For Long, there is been a lot of uncertainty in terms of legalities in the United States about the cryptocurrency, but Ohio took a step ahead. Recently, it has become the first state to accept Bitcoin to pay the taxes. As noted by the WSJ (Wall St ...

Jan-2018 |Electrical & Electronic

Study Claims That Mobile Apps Enhance Mental Health Thus Fueling The Global Smartphone Application Market

People undergoing mental health issues can reinforce their psychological well-being via mobile apps, a new survey claimed. The study, posted in the journal JMIR Mental Health, claimed that users who grapple with emotional and mental health issues ...

Jan-2018 |Medical & Health

Government Controlling Drugs And Prices Impacting Pharmaceuticals Market

The central government is preparing to curb the prices of combine drugs, which include 14 types of drugs. These drugs are used in the treatment of diseases such as high blood pressure, sugar, and cholesterol. The Nationa ...

Jan-2018 |ICT and Media

Two lakh Job In IT Sector Depicting Solid Growth In The Market

Last year, there was little interference for jobs in India but the scenario of jobs looks better in 2018. This year, there is hope for more than two lakh jobs in the information technology sector.

According to data, the Indian employment ...